Showing results (1731-1740 of 1,866) with videos related to
Sort By:
Pageof 187
Stroke|November 18, 2017
Mobile Interventional Stroke Teams Lead to Faster Treatment Times for Thrombectomy in Large Vessel OcclusionDaniel Wei, Thomas J Oxley, Dominic A Nistal, et al.The Journal of Urology|April 1, 2014
Alterations in resting state oscillations and connectivity in sensory and motor networks in women with interstitial cystitis/painful bladder syndromeLisa A Kilpatrick, Jason J Kutch, Kirsten Tillisch, et al.Inflammatory Bowel Diseases|May 17, 2019
Challenges in IBD Research: Environmental TriggersShuk-Mei Ho, James D Lewis, Emeran A Mayer, et al.Neurosurgical Focus|March 1, 2022
Cardiac arrest in spontaneous subarachnoid hemorrhage and associated outcomesEric Feldstein, Jose F Dominguez, Gurkamal Kaur, et al.Pain|March 23, 2017
Resting-state functional connectivity predicts longitudinal pain symptom change in urologic chronic pelvic pain syndrome: a MAPP network studyJason J Kutch, Jennifer S Labus, Richard E Harris, et al.Science Advances|September 13, 2024
Landau-phonon polaritons in Dirac heterostructuresLukas Wehmeier, Suheng Xu, Rafael A Mayer, et al.The Journal of Physiology|March 8, 2026
Augmenting erythropoiesis using recombinant human erythropoietin at sea level blunts the high altitude induced increase in erythropoiesisRoy M Salgado, Thomas A Mayer, Gabrielle E W Giersch, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 21, 2018
Paclitaxel With Inhibitor of Apoptosis Antagonist, LCL161, for Localized Triple-Negative Breast Cancer, Prospectively Stratified by Gene Signature in a Biomarker-Driven Neoadjuvant TrialAditya Bardia, Marina Parton, Sherko Kümmel, et al.Cancer Discovery|May 4, 2021
Impact of HER2 Heterogeneity on Treatment Response of Early-Stage HER2-Positive Breast Cancer: Phase II Neoadjuvant Clinical Trial of T-DM1 Combined with PertuzumabOtto Metzger Filho, Giuseppe Viale, Shayna Stein, et al.JNCI Cancer Spectrum|September 6, 2021
Cancer Antigen 15-3/Mucin 1 Levels in CCTG MA.32: A Breast Cancer Randomized Trial of Metformin vs PlaceboPamela J Goodwin, Ryan J O Dowling, Marguerite Ennis, et al.Pageof 187